Jenburkt Pharmaceuticals has informed that pursuant to Clause 42(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the record date is fixed as 19.03.2020 for the purpose of payment of Interim Dividend, if any, to be considered at the Board Meeting to be held on 06.03.2020.
The above information is a part of company’s filings submitted to BSE.